PubMed Health⌕ Search

Biomedical subjects

H C Fehmann

Publications and source records attributed to H C Fehmann.

95 records · Page 6Linked to original sources

Impairment of stimulated insulin release from the isolated perfused rat pancreas by cyclosporine pretreatment.

Cyclosporine was fed to male Wistar rats in a dose of 5, 10, or 50 mg/kg b.wt. for 7 days, and the effect on insulin secretion from the isolated perfused pancreas was investigated. Dose-dependently plasma insulin and pancreatic insulin content decreased while whole-blood CsA levels increased. An increase in blood glucose was only observed after feeding 50 mg/kg b.wt. CsA resulting in whole-blood CsA levels of 7735 ng/ml. Glucose (20 mM)-stimulated total insulin secretion (ng/50 min) was not affected during feeding 5 mg/kg b.wt. CsA, but was significantly reduced after feeding 10 or 50 mg/kg b.wt. CsA. The biphasic insulin secretion was reduced after 5 mg/kg b.wt. during the initial peak (0-10 min) but not during the second peak (10-50 min), whereas after 10 or 50 mg/kg b.wt. CsA both peaks were markedly reduced. The arginine (20 mM) and the arginine (20 mM)-plus-glucose (20 mM) stimulated insulin secretion was less affected after feeding 10 mg/kg b.wt. CsA than after stimulation with glucose (20 mM) alone. The addition of CsA to the perfusate did not influence glucose-stimulated insulin release from normal rat pancreas. Our results demonstrate a toxic effect of CsA on the pancreatic beta cell that is dose dependent and possibly influences both insulin secretion and biosynthesis.

Animals↗

Signal transmission after GLP-1(7-36)amide binding in RINm5F cells.

Glucagon-like peptide-1(7-36)amide [GLP-1(7-36)amide], probably representing an important incretin, binds to receptors on RINm5F cells resulting in an adenosine 3',5'-cyclic monophosphate increase. Guanine nucleotides (GTP, GTP-gamma-S, GDP-beta-S) decreased the binding of GLP-1(7-36)amide to receptors on RINm5F cell membranes. Further analysis revealed that GTP (10(-4) M) decreased the receptor affinity with an increase of the Kd from 2.5 +/- 0.99 x 10(-10) M to 9.43 +/- 2.16 x 10(-10) M. In cross-linking experiments the amount of labeled peptide linked to receptors was reduced in the presence of GTP (10(-4) M). Further studies investigated the involvement of membrane depolarization or changes in the cytosolic free calcium level in the intracellular signaling of GLP-1(7-36)amide-induced insulin secretion. In contrast to fuel and nonfuel secretagogues, GLP-1(7-36)amide did not cause a depolarization of the membrane potential. This was unaffected by various glucose concentrations (0-20 mM) or by previous cell depolarization by D-glyceraldehyde. Similarly, the cytosolic calcium concentration remained unchanged after addition of GLP-1(7-36)amide (10(-12)-10(-8) M). The effect of guanine nucleotides on binding of GLP-1(7-36)amide indicates that the action of the peptide is mediated by the adenylate cyclase system. GLP-1(7-36)amide binding neither changed the membrane potential nor altered the intracellular calcium concentration, making an involvement of the inositol 1,4,5-trisphosphate pathway or an activation of protein kinase C in the postreceptor signaling after GLP-1(7-36)amide binding unlikely.

Adenoma, Islet Cell↗

Influence of an absorbable alpha-glucosidase inhibitor (Bay o 1248) on the endocrine and exocrine pancreas of the rat.

The influence of an absorbable glucosidase inhibitor (Bay o 1248) on the endocrine and exocrine rat pancreas was evaluated. Rats fed a standard diet containing Bay o 1248 over 10 days consumed less food, gained about 30% less body weight than controls and showed meteorism. In these animals postprandial plasma insulin and glucose levels were decreased, but the total pancreatic insulin content was not different versus controls. The early insulin secretory response studied by pancreas perfusions was found reduced after a stimulatory glucose load (10 mM). Addition of the glucosidase inhibitor (1 mM) to the incubation medium diminished the glucose-induced insulin release from isolated islets of rats fed a standard diet. The compound added to the perfusion medium (10 microM) induced a slight reduction of half-maximal glucose-induced (10 mM) insulin release from the perfused pancreas. This inhibitory effect disappeared during maximal stimulation (20 mM glucose) of insulin secretion. The compound neither altered basal nor arginine-induced (15 mM) insulin release from the perfused organ. The exocrine pancreas was studied after feeding a Bay o 1248-enriched standard diet over 10 days. Amylase and trypsin concentration and total output into the biliary-pancreatic juice in response to CCK and secretin (20 IU or CU/kg body weight each) were diminished. The pancreatic enzyme content did not differ compared to controls. A significant role of carbohydrate maldigestion, systemic effects of the glucosidase inhibitor, and endocrine-exocrine pancreatic interrelations are discussed to account for the effects of the compound on the rat pancreas.

1-Deoxynojirimycin↗